Loading cancer entity…
Loading cancer entity…
Variants & evidence
30 evidence items mapped to this entity or its descendants, grouped by molecular profile, then therapy. 50 items per page.
| Therapy | Cancer | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| CCNB3 Fusion3 | ||||||||
| (diagnostic) | Sarcoma with BCOR Genetic Alterations | Diagnostic | B | Supports Positive | 4 | accepted | EID9011This study consists of a cohort of 42 pediatric and adult patients with sarcomas that were classified as undifferentiated. Six of the forty two patients had BCOR::CCNB3 fusions detected by whole trans… (full text at CIViC) PMID 25360585 · Peters et al., 2015 · Open in CIViC | civic |
| 〃 | Sarcoma with BCOR Genetic Alterations | Diagnostic | B | Supports Positive | 3 | accepted | EID10111Kao, et al. (2018) presented 36 BCOR::CCNB3 sarcoma cases (86% were males; mean and median age at presentation was 15 years (range from 2 to 44 years); 78% showed mainly primitive round cells morpholo… (full text at CIViC) PMID 29300189 · Kao et al., 2018 · Open in CIViC | civic |
| 〃 | Sarcoma with BCOR Genetic Alterations | Diagnostic | B | Supports Positive | 3 | accepted | EID12568In this 2017 study reviewing 753 sarcoma cases, 11 tumors with the BCOR::CCNB3 fusion were identified using immunohistochemistry and RT-PCR. These tumors were found exclusively in males, with a mean a… (full text at CIViC) PMID 28420319 · Ludwig et al., 2017 · Open in CIViC | civic |
| CCNB3 Fusion + MAML3 FusionCCNB3MAML31 | ||||||||
| (diagnostic) | Sarcoma with BCOR Genetic Alterations | Diagnostic | B | Supports Positive | 3 | accepted | EID11590BCOR expression was evaluated in a cohort of 25 small blue round cell tumors (SBRCTs) with BCOR fusions (BCOR::MAML3, BCOR::CCNB3), BCOR exon 15 ITDs, or YWHAE-NUTM2B fusion (which is known to upregul… (full text at CIViC) PMID 27428733 · Kao et al., 2016 · Open in CIViC | civic |
| DUX4 Fusion4 | ||||||||
| (diagnostic) | CIC-Rearranged Sarcoma | Diagnostic | B | Supports Positive | 4 | accepted | EID9012This study consists of a cohort of 115 patients with a class of sarcomas that had similar morphology to Ewing sarcoma. The presence of a CIC rearrangement was detected in all the cases by FISH. Previo… (full text at CIViC) PMID 28346326 · Antonescu et al., 2017 · Open in CIViC | civic |
| 〃 | CIC-Rearranged Sarcoma | Diagnostic | B | Supports Positive | 3 | accepted | EID11594The authors recognize that differentiating between Ewing sarcoma and CIC::DUX4 fusion associated sarcoma can be challenging due to overlapping histological and immunohistochemical phenotypes. In this… (full text at CIViC) PMID 35151033 · Song et al., 2022 · Open in CIViC | civic |
| 〃 | CIC-Rearranged Sarcoma | Diagnostic | B | Supports Positive | 3 | |||
| NUTM1 Fusion + NUTM2B Fusion + DUX4 Fusion + LEUTX Fusion + NUTM1 Fusion + NUTM2B Fusion + DUX4 FusionDUX4LEUTXNUTM1NUTM2B1 | ||||||||
| (diagnostic) | CIC-Rearranged Sarcoma | Diagnostic | B | Supports Positive | 4 | submitted | EID12515The cohort included 44 CIC-rearranged sarcomas (CIC-RS), comprising 18 central nervous system (CNS) and 26 extra-CNS tumors. RNA sequencing (n=27) identified CIC::DUX4 (n=15), CIC::NUTM1 (n=4), CIC::L… (full text at CIViC) PMID 39985394 · Koo et al., 2025 · Open in CIViC | civic |
| NFATC2 Fusion3 | ||||||||
| (diagnostic) | Round Cell Sarcoma with EWSR1-non-ETS Fusion | Diagnostic | B | Supports Positive | 3 | accepted | EID11604This analysis of small round cell tumors of the bone identified 3 with EWSR1::NFATC2 fusions and 1 with a FUS::NFATC2 fusion. The authors extended their review to an additional 45 cases in the litera… (full text at CIViC) PMID 31078563 · Diaz-Perez et al., 2019 · Open in CIViC | civic |
| 〃 | Round Cell Sarcoma with EWSR1-non-ETS Fusion | Diagnostic | C | Supports Positive | 3 | accepted | EID12590A small case series examined molecular features along with clinicopathologic and immunohistochemical characteristics of sarcomas with EWSR1::NFATC2 gene fusions. The study included 6 cases (5 males an… (full text at CIViC) PMID 30994538 · Wang et al., 2019 · Open in CIViC | civic |
| 〃 | Round Cell Sarcoma with EWSR1-non-ETS Fusion | Diagnostic | C | Supports | ||||
| PATZ1 Fusion4 | ||||||||
| (diagnostic) | Round Cell Sarcoma with EWSR1-non-ETS Fusion | Diagnostic | C | Supports Positive | 3 | accepted | EID12735This case series study reported 11 neoplasms harboring the EWSR1::PATZ1 gene fusion with 7 in the soft tissue and 4 in the brain. Paired-end sequencing identified a somatic intra-chromosomal paracentr… (full text at CIViC) PMID 31189996 · Bridge et al., 2019 · Open in CIViC | civic |
| 〃 | Round Cell Sarcoma with EWSR1-non-ETS Fusion | Diagnostic | C | Supports Positive | 3 | accepted | EID12738This case series study presented clinical, histopathological, and molecular findings of 9 EWSR1::PATZ1-rearranged sarcomas, including one previously reported case. The cohort included 4 males and 5 fe… (full text at CIViC) PMID 33012788 · Michal et al., 2021 · Open in CIViC | civic |
| 〃 | Round Cell Sarcoma with EWSR1-non-ETS Fusion | Diagnostic | C | Supports | ||||
| WT1 Fusion3 | ||||||||
| (diagnostic) | Desmoplastic Small Round Cell Tumor | Diagnostic | B | Supports Positive | 2 | accepted | EID11405In an analysis of a cohort of desmoplastic small round cell tumor, evidence of a functional EWSR1::WT1 fusion was detected in 25 of 26 cases. In these cases, the genomic breakpoints in WT1 was in in… (full text at CIViC) PMID 9738572 · Gerald et al., 1998 · Open in CIViC | civic |
| 〃 | Desmoplastic Small Round Cell Tumor | Diagnostic | B | Supports Positive | 2 | accepted | EID11406In an analysis of 6 desmoplastic small round cell tumors, chimeric EWSR1::WT1 transcripts were detected in 4. The translocation resulted in an in-frame fusion of the N terminus (first 7 exons) of EWS… (full text at CIViC) PMID 7862627 · Gerald et al., 1995 · Open in CIViC | civic |
| 〃 | Desmoplastic Small Round Cell Tumor | Diagnostic | C | Supports Positive | ||||
| NFATC2 Fusion3 | ||||||||
| (diagnostic) | Round Cell Sarcoma with EWSR1-non-ETS Fusion | Diagnostic | B | Supports Positive | 3 | accepted | EID11605This analysis of small round cell tumors of the bone identified 3 with EWSR1::NFATC2 fusions and 1 with a FUS::NFATC2 fusion. The authors extended their review to an additional 45 cases in the litera… (full text at CIViC) PMID 31078563 · Diaz-Perez et al., 2019 · Open in CIViC | civic |
| 〃 | Round Cell Sarcoma with EWSR1-non-ETS Fusion | Diagnostic | C | Supports Positive | 3 | accepted | EID12693This is the first study to identify the FUS::NFATC2 gene fusion. Using multi-omics approach and targeted sequencing, the authors comprehensively characterized the molecular landscape of a large cohort… (full text at CIViC) PMID 25010205 · Brohl et al., 2014 · Open in CIViC | civic |
| 〃 | Round Cell Sarcoma with EWSR1-non-ETS Fusion | Diagnostic | C | Supports | ||||
| NCOA2 Fusion8 | ||||||||
| (diagnostic) | Mesenchymal Chondrosarcoma | Diagnostic | B | Supports Positive | 4 | accepted | EID7008A HEY1-NCOA2 fusion joining exon 4 of HEY1 to exon 13 of NCOA2 was identified in 10 mesenchymal chondrosarcomas but was absent from all other sarcoma types tested including other chondrosarcoma subtyp… (full text at CIViC) PMID 22034177 · Wang et al., 2012 · Open in CIViC | civic |
| 〃 | Mesenchymal Chondrosarcoma | Diagnostic | B | Supports Positive | 4 | submitted | EID7025Meningeal hemangiopericytoma (HPC) and mesenchymal chondrosarcoma (MC) are aggressive neoplasms with overlapping clinical presentations and morphology. Thirteen FFPE samples of MC (9 females, 4 males)… (full text at CIViC) PMID 24124145 · Fritchie et al., 2013 · Open in CIViC | civic |
| 〃 | Mesenchymal Chondrosarcoma | Diagnostic | B | Supports Positive | 4 | |||
Data updated 1 hour agoSource updated unknownsource: civic (CC0)
Evidence levels, directions and ratings are those assigned by CIViC curators. "Submitted" items have not completed curation review. This is not treatment guidance.
EID11595In this 2012 paper, 22 small blue round cell tumors that remained unclassified after screening for known sarcoma-related translocations, were analyzed for CIC and FUS rearrangements. 68% (15/22) were… (full text at CIViC) PMID 22072439 · Italiano et al., 2012 · Open in CIViC |
| civic |
| (oncogenic) | CIC-Rearranged Sarcoma | Oncogenic | C | Supports Oncogenicity | 3 | accepted | EID10112Kawamura-Saito, et al. (2006) presented 2 soft tissue Ewing-like sarcoma cases (62 years of age female who deceased 10 months after biopsy; 31 years of age male who was without recurrence 30 months af… (full text at CIViC) PMID 16717057 · Kawamura-Saito et al., 2006 · Open in CIViC | civic |
| 3 |
| accepted |
EID12591This landmark study represents the first description of the EWSR1::NFATC2 fusion in Ewing-like sarcomas, leading to the establishment of 'round cell sarcoma with EWSR1-non-ETS fusions' as a new diseas… (full text at CIViC) PMID 19318479 · Szuhai et al., 2009 · Open in CIViC |
| civic |
| 3 |
| rejected |
EID12739This case series study presented clinical, histopathological, and molecular findings of 9 EWSR1-PATZ1-rearranged sarcomas, including one previously reported case (case 3). The cohort included 4 males … (full text at CIViC) PMID 38043789 · Dehner et al., 2024 · Open in CIViC |
| civic |
| 〃 | Round Cell Sarcoma with EWSR1-non-ETS Fusion | Diagnostic | C | Supports Positive | 3 | accepted | EID12740This study presented molecular and clinicopathologic findings of a cohort of 17 EWSR1::PATZ1 soft tissue sarcomas. These tumors occurred in 12 males and 5 females with 15-71 years of age (median age, … (full text at CIViC) PMID 38043789 · Dehner et al., 2024 · Open in CIViC | civic |
| 2 |
| accepted |
EID11407Molecular analysis of desmoplastic small round cell tumors with recurrent translocation, t(11;22) (p13;q12) identified EWSR1 on 22q12 and WT1 on 11p13 as the genes involved in the rearrangement. Furt… (full text at CIViC) PMID 8187063 · Ladanyi et al., 1994 · Open in CIViC |
| civic |
| 2 |
| accepted |
EID12692This case series presented 7 NFATC2-rearranged sarcomas, including 4 EWSR1::NFATC2 and 3 FUS::NFATC2 cases, and developed an ACAN-encoding aggrecan immunohistochemistry as a diagnostic tool for these … (full text at CIViC) PMID 32327700 · Perret et al., 2020 · Open in CIViC |
| civic |
| submitted |
EID7026FISH was used to detect HEY1-NCOA2 fusions in 10 paraffin embedded samples from patients diagnosed with mesenchymal chondrosarcoma. HEY1 and NCOA2 are located on same chromosome but generate distinct … (full text at CIViC) PMID 23252872 · Nakayama et al., 2012 · Open in CIViC |
| civic |
| 〃 | Mesenchymal Chondrosarcoma | Diagnostic | B | Supports Positive | 4 | accepted | EID7124FISH was used to detect HEY1-NCOA2 fusions in 10 paraffin embedded samples from patients diagnosed with mesenchymal chondrosarcoma. HEY1 and NCOA2 are located on the same chromosome but generate disti… (full text at CIViC) PMID 23252872 · Nakayama et al., 2012 · Open in CIViC | civic |
| 〃 | Mesenchymal Chondrosarcoma | Diagnostic | B | Supports Positive | 4 | accepted | EID7125Meningeal hemangiopericytoma (HPC) and mesenchymal chondrosarcoma (MC) are aggressive neoplasms with overlapping clinical presentations and morphology. Thirteen FFPE samples of MC (9 females, 4 males)… (full text at CIViC) PMID 24124145 · Fritchie et al., 2013 · Open in CIViC | civic |
| 〃 | Mesenchymal Chondrosarcoma | Diagnostic | B | Supports Positive | 2 | accepted | EID70176 of 6 patients with mesenchymal chondrosarcoma and sufficient tissue tested positive for NCOA2 rearrangments by FISH supporting that NCOA2 rearrangements (presumably HEY1-NCOA2 translocations) are pr… (full text at CIViC) PMID 26146478 · Bishop et al., 2015 · Open in CIViC | civic |
| Imatinib | Mesenchymal Chondrosarcoma | Predictive | D | Supports Sensitivity Response | 2 | submitted | EID10798In two independent in-vitro and PDX models of HEY1::NCOA2 fusion positive mesenchymal chondrosarcoma, imatinib demonstrated a highly selective cytotoxic effect and reduction of growth. PMID 34837064 · Safaric Tepes et al., 2022 · Open in CIViC | civic |
| Trabectedin | Mesenchymal Chondrosarcoma | Predictive | C | Supports Sensitivity Response | 2 | accepted | EID12585In a sub-analysis of a randomized phase II trial in extraskeletal myxoid chondrosarcoma (EWSR1-NR4A3 and TAF15-NR4A3 fusions) and mesenchymal chondrosarcoma (HEY1-NCOA2 fusion)(trabectedin n = 5; BSC … (full text at CIViC) PMID 27418251 · Morioka et al., 2016 · Open in CIViC | civic |